GFH-375
- Generic Name
- GFH-375
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Target Recruit Count
- 390
- Registration Number
- NCT06500676
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath